Pharma Excipients
Sustained Release Agent
Benchmarking pharmaceutical quality and manufacturing costs of 3D printing against conventional…
Abstract
Background: Modification of commercially available medicine, e.g. splitting or dissolving of tablets or pharmacy compounding, is current clinical practice when desired oral dosage forms are unavailable. These practices are defined as conventional pharmacy compounding techniques and are…
Read More...
Read More...
Coatings Portfolio from BASF Pharma Solutions
BASF Pharma Solutions offers film-forming polymers and additive chemistries for your aesthetic, protective, and functional coating needs.
BASF’s Kollicoat® portfolio provides easy-to-use coating options based on your tablet’s needs and desired functionality. Products from our Kolliphor®,…
Read More...
Read More...
Sustained-release tablets prepared by compression coating technology achieve similar drug release to…
Abstract
Over the past decades, a variety of controlled-release technologies have been developed to maintain a constant drug release rate in vivo. Osmotic pumps offer precise control and are widely used in marketed formulations. However, the manufacturing of osmotic pump tablets often involves…
Read More...
Read More...
A drug delivery perspective on nanotechnology-based topical therapeutics for inflammatory skin…
Abstract
Inflammatory skin diseases are chronic conditions that significantly affect patients’ skin health and quality of life. Traditional treatments, including systemic immunosuppressants and topical therapies, often face limitations such as low efficacy, inadequate skin penetration, and severe…
Read More...
Read More...
Development of long-acting imidafenacin transdermal patches with high drug loading based on solid…
Abstract
Imidafenacin tablets are the first-line drug for the treatment of overactive bladder (OAB). However, the tablets need to be taken twice daily for up to 3–6 months, which highly reduces patient compliance. This study aimed to develop a long-acting imidafenacin transdermal patch (LAITP) with…
Read More...
Read More...
Development of Gastro-Retentive Combination Formulation of Montelukast Sodium and Bepotastine…
Abstract
Aim: The study aimed to develop a once-daily sustained-release gastroretentive combination formulation of bepotastine besilate and montelukast sodium using multilayer tablet technology and gastro-retentive systems for the treatment of allergic rhinitis and asthma.
Background:…
Read More...
Read More...
Development of Eudragit®-Coated Linezolid-Loaded Lipid Nanoparticles for Enhanced Ocular Delivery in…
Abstract
Linezolid (LNZ), oxazolidinone antibiotic, is widely used in clinical practice for treatment of bacterial keratitis. Despite its efficacy, the application of LNZ in ophthalmic delivery is hindered by significant precorneal drug loss and poor ocular bioavailability. In this study,…
Read More...
Read More...
Sustained Release Capsules Manufacturing and Handling
Patients and caregivers experience challenges following a prescribed medicine routine. If the active pharmaceutical ingredients (API) are released quickly then patients may require multiple doses of the drug. That is to maintain treatment effectiveness. Uneven treatment and adverse effects can arise…
Read More...
Read More...
Advances in the Oral Delivery of Protein and Peptide Drugs
Abstract
Protein and peptide drugs (PPDs) are highly effective therapies for a wide range of diseases, including cancer, diabetes, and autoimmune disorders . However, delivering these drugs orally presents significant challenges. PPDs face substantial barriers to attaining oral bioavailability,…
Read More...
Read More...
PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and…
Abstract
Poly(lactide-co-glycolide) (PLGA) implants have become a cornerstone in drug delivery and regenerative medicine due to their biocompatibility, tunable degradation, and capacity for sustained, localized therapeutic release. Recent innovations in polymer design, fabrication methods, and…
Read More...
Read More...